Epilepsy Journey-An Executive Functioning Intervention for Teens With Epilepsy

Eligibility Criteria

• 1. Age between 13-17 years at the time of enrollment
• 2. Child lives at home with primary caregiver and is enrolled in school (excluding summer breaks).
• 3. Confirmed diagnosis of epilepsy with seizures that are categorized as either generalized or focal in onset. Epilepsy is defined as: 1) At least two unprovoked seizures occurring more than 24-hours apart; or 2) One unprovoked seizure and a probability of further seizures similar to the general recurrence risk after two unprovoked seizures.
• 4. Primary language of English
• 5. Screening Inclusion: On the parent-reported Behavior Rating Inventory of Executive Function-2nd edition (BRIEF-2), have executive functioning deficits defined as at least 2 subclinical (60\<T\<65) or one clinical BRIEF-2 subscale T scores (T≥65).
• 6. Parent/legal guardian(s) willing to sign an IRB approved informed consent
• 7. Participant willing to sign an Institutional Review Board approved assent
• 1. Parent or clinician-reported history in the adolescent of:
• 1. developmental delay (e.g., autism spectrum disorder, pervasive development disorder, history of services for developmental delay or intellectual impairment in the past 5 years, known IQ\<70)
• 2. severe mental illness (e.g., schizophrenia, bipolar disorder, eating disorder within the past 12 months, depression with active suicidal ideation or suicidal ideation/intent in the past 3 months)
• 3. prior (3-months) or current history of trauma and/or stressor-related disorders (e.g. PTSD)
• 4. recent or current significant medical disease (i.e., cardiovascular, hepatic, renal, gynecologic, musculoskeletal, metabolic or endocrine)
• 5. brain injury or brain tumor; and/or
• 6. epilepsy surgery
• 7. any other medical and/or psychological condition that takes treatment precedence over the study intervention
• 2. Clinician-reported diagnosis in the adolescent of
• 1. epilepsy whose seizures are categorized only as either unknown onset or unclassified onset (defined as insufficient information to determine onset)
• 2. epilepsy currently being treated at the time of enrollment by 3 or more antiseizure medications (ASMs) (excluding rescue medication use)
• 3. epilepsy with a history of failure to achieve seizure freedom despite adequate use of 4 different anti-seizure medications
• 4. a confirmed or suspected epileptic encephalopathy (e.g., electrical status epilepticus in sleep, Landau Kleffner syndrome, West syndrome)
• 5. a confirmed or suspected progressive and degenerative disorder (e.g., mitochondrial disorders, metabolic disorders, autoimmune disorders)
• 6. one or more episodes of status epilepticus within the 24 weeks prior to enrollment; and/or
• 7. treatable causes of seizures, for example identified etiologies including metabolic, neoplastic, or active infectious origin.
• 8. non-epileptic event/seizures
• 3. Adolescents currently on the ketogenic diet
• 4. Participation in a trial of an investigational drug or device within 30 days prior to screening